Incannex Healthcare (IHL) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock IHL Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Incannex Healthcare Stock Sees Retail Chatter Explode 234% Over Last WeekSeptember 24, 2025 | msn.com3 Penny Stocks to Watch Now, 8/28/25August 28, 2025 | tipranks.comIncannex Reports Positive Phase 2 Trial ResultsAugust 26, 2025 | msn.com3 Penny Stocks to Watch Now, 8/26/25August 26, 2025 | tipranks.comIncannex stock surges after positive sleep apnea trial resultsAugust 8, 2025 | investing.comIncannex drops despite mid-stage trial win for lead asset in sleep apnoeaJuly 30, 2025 | msn.comIncannex Shares Climb 10% After Sleep Apnea Drug Shows Strong Phase 2 ResultsJuly 30, 2025 | msn.comIncannex Flat on Looking Ahead to Clinical TrialJune 18, 2025 | baystreet.caIncannex Healthcare Reports Improved Financial PerformanceJune 6, 2025 | tipranks.comIncannex Healthcare Inc. Appoints Four Experts to IHL-42X Obstructive Sleep Apnea Clinical Advisory BoardJune 4, 2025 | nasdaq.comIncannex Surges 720% On Sleep Apnea Trial Progress: ‘Penny Bio Pharma Mania’ Lifts Retail SentimentMay 15, 2025 | msn.comIncannex completes Phase 2 patient enrollment for RePOSA study of IHL-42XApril 4, 2025 | markets.businessinsider.comIncannex Healthcare Limited Reports Quarterly FinancialsFebruary 18, 2025 | tipranks.comIncannex reports Q2 EPS (33c) vs (33c) last yearFebruary 14, 2025 | markets.businessinsider.comIncannex appoints Alison Wimms to IHL-42X OSA Clinical Advisory BoardFebruary 4, 2025 | markets.businessinsider.comIncannex announces results from PK study of IHL-42XJanuary 24, 2025 | markets.businessinsider.comIncannex files to sell 61.39M shares of common stock for holdersNovember 8, 2024 | markets.businessinsider.comIncannex Healthcare: Incannex Announces Appointment of Dr. Lou Barbato as Chief Medical OfficerOctober 24, 2024 | finanznachrichten.deStonegate Initiates Coverage on Incannex Healthcare Inc. (NasdaqGM:IXHL)October 4, 2024 | benzinga.comIncannex secures $60 million in funding for clinical trialsSeptember 12, 2024 | uk.investing.comFDA Clears Incannex To Proceed With Phase 2 Psilocybin-Assisted Therapy Trial For AnxietyAugust 5, 2024 | benzinga.comIncannex Healthcare Inc. Quarterly Update, Q1 2024April 16, 2024 | finance.yahoo.comWhat's Going On With Incannex Stock?February 28, 2024 | msn.comIncannex Healthcare Inc.December 27, 2023 | wsj.comIncannex Healthcare: Clarion Clinics Receives Ethics Board Endorsement for the First Dedicated Psychedelic-Assisted Therapy Clinic in AustraliaDecember 22, 2023 | finanznachrichten.deIncannex Healthcare Inc. (IXHL)December 6, 2023 | uk.finance.yahoo.comThese 3 Biotech Stocks More Than Doubled in November. Can They Fly Even Higher in 2024?December 2, 2023 | msn.comIncannex Healthcare Announces Completion of its Redomiciliation to the United StatesNovember 29, 2023 | finance.yahoo.comIncannex Healthcare to present at the H.C. Wainwright 25th...Incannex Healthcare to present at the H.C. Wainwright 25th Annual...September 7, 2023 | proactiveinvestors.comCompanies Like Incannex Healthcare (ASX:IHL) Are In A Position To Invest In GrowthSeptember 6, 2023 | finance.yahoo.com‘Frontrunner within the psychedelics’ : Incannex prepares to file psilocybin US FDA application ahead of Nasdaq UplistingAugust 25, 2023 | msn.comIncannex Healthcare prepares psilocybin therapy FDA IND applicationAugust 23, 2023 | proactiveinvestors.com.auIncannex full steam ahead towards sleep apnoea trialAugust 22, 2023 | proactiveinvestors.comFDA clears Incannex’s IND for trial of obstructive sleep apnoea therapyAugust 22, 2023 | msn.comReview of IND Application for IHL-42X by US FDA has been completed; Clinical Trial for Patients with Obstructive Sleep Apnoea May ProceedAugust 22, 2023 | finance.yahoo.comIncannex gets green light from US FDA for Phase 2/3 Pivotal Clinical Trialfor obstructive sleep apnoeaAugust 22, 2023 | msn.comIncannex Healthcare receives US FDA approval for sleep apnoea clinical trialAugust 21, 2023 | proactiveinvestors.comIncannex’s subsidiary Clarion Clinics prepares to take first clients for psychedelic treatmentAugust 9, 2023 | msn.comClarion Clinics Begins Accepting Registrations For Psychedelic Treatment InterestAugust 8, 2023 | benzinga.comIncannex Healthcare June 2023 Quarterly Activities Report and Appendix 4C Cash Flow StatementJuly 28, 2023 | finance.yahoo.comIncannex thrilled with positive pre-IND meeting for arthritis treatmentJuly 28, 2023 | finance.yahoo.comIncannex has positive Pre-IND meeting with US FDA on IHL-675A for treatment of Rheumatoid ArthritisJuly 27, 2023 | msn.comIncannex Submits IND Application to the US FDA for IHL-42X for Obstructive Sleep ApnoeaJuly 21, 2023 | finance.yahoo.comIncannex engages Fortrea to Manage its FDA IND Opening Phase 2/3 Clinical Trial Investigating IHL-42X for Treatment of Obstructive Sleep ApnoeaJuly 18, 2023 | finance.yahoo.comFIVE at FIVE AU: Russians hack Fortescue; hawkish RBA minutes send ASX lowerJuly 18, 2023 | proactiveinvestors.com.auIncannex appoints CRO ahead of Phase 2/3 sleep apnoea trialJuly 18, 2023 | proactiveinvestors.com.auIncannex engages Fortrea for major clinical trial looking at IHL-42X for sleep apnoeaJuly 17, 2023 | msn.comIncannex Healthcare engages Fortrea to manage next clinical trial stage investigating IHL-42X for Obstructive Sleep ApnoeaJuly 17, 2023 | proactiveinvestors.comIncannex Receives HREC Approval For Phase 2 Clinical Trial Of CBD-Based Drug For Use In Treatment Of Rheumatoid ArthritisJuly 13, 2023 | msn.comIncannex Receives HREC Approval for Phase 2 Clinical Trial Assessing IHL-675A for use in Treatment of Pain and Function in Rheumatoid ArthritisJuly 13, 2023 | finance.yahoo.com Get Incannex Healthcare News Delivered to You Automatically Sign up to receive the latest news and ratings for IHL and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. IHL Media Mentions By Week IHL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IHL News Sentiment▼0.000.63▲Average Medical News Sentiment IHL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IHL Articles This Week▼00▲IHL Articles Average Week Get the Latest News and Ratings for IHL and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Incannex Healthcare and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies BXP News HLS News ANCR News RX News CRDL News MDP News DB News STX News VLG News EAH News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (ASX:IHL) was last updated on 10/9/2025 by MarketBeat.com Staff From Our PartnersBuilding The Infrastructure for the Coming Financial ResetWhile China pushes nearly $1 trillion through its new digital currency, one emerging company is quietly buildi...Intellistake | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Incannex Healthcare Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Incannex Healthcare With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
